Stay updated on Pediatric Fevipiprant Chewable Tablet Clinical Trial
Sign up to get notified when there's something new on the Pediatric Fevipiprant Chewable Tablet Clinical Trial page.

Latest updates to the Pediatric Fevipiprant Chewable Tablet Clinical Trial page
- Check6 days agoChange DetectedThe record describes a terminated Phase 2 study of fevipiprant in children aged 6–11 with asthma, including its design, eligibility criteria, locations, and pharmacokinetic outcomes. It also provides study results and documents, along with information about sharing participant-level data.SummaryDifference51%

- Check13 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0. The study record page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA site-wide NIH banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe displayed ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1, while the page continues to show a 403 error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe record page now displays a 403 Forbidden error with a minimal header, removing the study details and links and effectively blocking access to the trial information.SummaryDifference18%

- Check62 days agoChange DetectedThe page revision label was updated from v3.6.6 to v3.7.0, indicating a deployment/version update. No visible study details appear to have changed.SummaryDifference0.1%

Stay in the know with updates to Pediatric Fevipiprant Chewable Tablet Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Fevipiprant Chewable Tablet Clinical Trial page.